INDEGENE
Quarterly Results Analysis [Mar2025]
INDEGENE Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹756 Cr | ₹720 Cr | ₹687 Cr | ₹677 Cr | ₹673 Cr | ₹673 Cr | ₹636 Cr | ₹608 Cr |
Expenses | ₹608 Cr | ₹589 Cr | ₹561 Cr | ₹548 Cr | ₹534 Cr | ₹525 Cr | ₹515 Cr | ₹511 Cr |
Operating Income | ₹148 Cr | ₹132 Cr | ₹126 Cr | ₹129 Cr | ₹139 Cr | ₹149 Cr | ₹121 Cr | ₹97 Cr |
Other Income | ₹26 Cr | ₹38 Cr | ₹21 Cr | ₹23 Cr | ₹23 Cr | ₹13 Cr | ₹12 Cr | ₹29 Cr |
Interest | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
Depreciation | ₹21 Cr | ₹20 Cr | ₹19 Cr | ₹20 Cr | ₹19 Cr | ₹18 Cr | ₹20 Cr | ₹20 Cr |
Profit Before Tax | ₹149 Cr | ₹146 Cr | ₹124 Cr | ₹120 Cr | ₹134 Cr | ₹132 Cr | ₹101 Cr | ₹93 Cr |
Profit After Tax | ₹118 Cr | ₹110 Cr | ₹92 Cr | ₹88 Cr | ₹95 Cr | ₹99 Cr | ₹75 Cr | ₹68 Cr |
EPS | ₹4.91 | ₹4.59 | ₹3.84 | ₹3.66 | ₹4.27 | ₹4.45 | ₹3.39 | ₹3.09 |
Industry Peers & Returns | 1W | 1M | 1Y |
INDEGENE | 3.2% | 3.7% | NA |
SUN PHARMACEUTICAL INDUSTRIES | -4.6% | 0.7% | 10.8% |
DIVIS LABORATORIES | -1.2% | 12.6% | 51.2% |
CIPLA | 0.7% | 6% | 9.2% |
TORRENT PHARMACEUTICALS | -1.8% | -0.4% | 25.1% |
DR REDDYS LABORATORIES | 4% | 8.9% | -1.3% |
MANKIND PHARMA | 4.9% | 8.7% | 14.6% |
ZYDUS LIFESCIENCES | 1.7% | 4.9% | -12% |
LUPIN | -0.4% | 4.1% | 26.3% |
INDEGENE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.89 % |
Y-o-Y | 12.27 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹756 Cr | 4.89 | |
Dec2024 | ₹720 Cr | 4.89 | |
Sep2024 | ₹687 Cr | 1.52 | |
Jun2024 | ₹677 Cr | 0.52 | |
Mar2024 | ₹673 Cr | -0.06 | |
Dec2023 | ₹673 Cr | 5.93 | |
Sep2023 | ₹636 Cr | 4.64 | |
Jun2023 | ₹608 Cr | - |
INDEGENE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 11.91 % |
Y-o-Y | 6.34 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹148 Cr | 11.91 | |
Dec2024 | ₹132 Cr | 4.52 | |
Sep2024 | ₹126 Cr | -2.17 | |
Jun2024 | ₹129 Cr | -7.07 | |
Mar2024 | ₹139 Cr | -6.85 | |
Dec2023 | ₹149 Cr | 22.96 | |
Sep2023 | ₹121 Cr | 25.10 | |
Jun2023 | ₹97 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 6.67 % |
Y-o-Y | -5.29 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 19.52% | 6.67 | |
Dec2024 | 18.3% | -0.33 | |
Sep2024 | 18.36% | -3.62 | |
Jun2024 | 19.05% | -7.57 | |
Mar2024 | 20.61% | -6.78 | |
Dec2023 | 22.11% | 16.06 | |
Sep2023 | 19.05% | 19.59 | |
Jun2023 | 15.93% | - |
INDEGENE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 7.20 % |
Y-o-Y | 24.05 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹118 Cr | 7.20 | |
Dec2024 | ₹110 Cr | 19.63 | |
Sep2024 | ₹92 Cr | 4.56 | |
Jun2024 | ₹88 Cr | -7.49 | |
Mar2024 | ₹95 Cr | -4.05 | |
Dec2023 | ₹99 Cr | 31.73 | |
Sep2023 | ₹75 Cr | 9.65 | |
Jun2023 | ₹68 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 2.17 % |
Y-o-Y | 10.43 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 15.56 % | 2.17 | |
Dec2024 | 15.23 % | 14.08 | |
Sep2024 | 13.35 % | 3.01 | |
Jun2024 | 12.96 % | -8.02 | |
Mar2024 | 14.09 % | -3.95 | |
Dec2023 | 14.67 % | 24.32 | |
Sep2023 | 11.8 % | 4.80 | |
Jun2023 | 11.26 % | - |
INDEGENE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 6.97 % |
Y-o-Y | 14.99 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹4.91 | 6.97 | |
Dec2024 | ₹4.59 | 19.53 | |
Sep2024 | ₹3.84 | 4.92 | |
Jun2024 | ₹3.66 | -14.29 | |
Mar2024 | ₹4.27 | -4.04 | |
Dec2023 | ₹4.45 | 31.27 | |
Sep2023 | ₹3.39 | 9.71 | |
Jun2023 | ₹3.09 | - |
You may also like the below Video Courses